CollPlant Biotechnologies
CLGN
CLGN
3 hedge funds and large institutions have $625K invested in CollPlant Biotechnologies in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
|
$594K |
| 2 |
HIIFS
2
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
$17K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$14K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MIH
1
Meitav Investment House
Bene-Beraq,
Israel
| $594K | 141,662 | +141,662 | New |
|
|
HIIFS
2
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| $17K | 4,106 | +4,106 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $14K | 3,316 | -6,515 | -66% |
|
|
4
Citadel Advisors
Miami,
Florida
| – | – | -13,885 | Closed |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|